CAS 851376-05-1

Pyrazolo[3,4-d]azepine,3-(4-chlorophenyl)-1,4,5,6,7,8-hexahydro-1-(phenylmethyl)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1)

Description:

Pyrazolo[3,4-d]azepine, 3-(4-chlorophenyl)-1,4,5,6,7,8-hexahydro-1-(phenylmethyl)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1) is a complex organic compound characterized by its unique bicyclic structure, which incorporates both a pyrazolo and an azepine moiety. This compound features multiple functional groups, including a chlorophenyl substituent and a tricarboxylate ester, contributing to its potential biological activity. The presence of the hexahydro framework indicates a saturated ring system, which may influence its reactivity and interactions with biological targets. The hydroxyl group suggests potential for hydrogen bonding, enhancing solubility and reactivity in various environments. This compound may exhibit pharmacological properties, making it of interest in medicinal chemistry, particularly in the development of therapeutic agents. Its specific interactions and efficacy would depend on further studies, including in vitro and in vivo evaluations. As with many complex organic compounds, careful consideration of its synthesis, stability, and safety profile is essential for practical applications.

Formula: C₂₀H₂₀ClN₃C₆H₈O₇

JNJ-18038683

CAS: 851376-05-1

JNJ-18038683 is a 5-Hydroxytryptamine Type 7 (5-HT7) receptor antagonist, with pKis of 8.19, 8.20 for rat and human 5-HT7 in HEK293 cells, respectively.

Formula: C₂₆H₂₈ClN₃O₇

Purity: 97.29%

Color and Shape: Solid

Molecular weight: 529.97

Ref: TM-T11720

JNJ-18038683

CAS: 851376-05-1

JNJ-18038683

Purity: ≥95%

Molecular weight: 529.97g/mol

Ref: 54-BUP09744

JNJ 18038683

CAS: 851376-05-1

Serotonin receptor 5-HT7 antagonist

Formula: C₂₀H₂₀ClN₃·C₆H₈O₇

Purity: Min. 95%

Molecular weight: 529.97 g/mol

Ref: 3D-BJ166487